Lam Research Corporation shares fell 29%, reshaping valuations as a $200 billion wafer fabrication boom boosts outlook. Click ...

Ionis Pharmaceuticals, Inc. is a long-term buy as launches, royalties, & pipeline growth boost revenue prospects despite cash ...

Genmab (GMAB) and Incyte (INCY) announced a clinical trial collaboration to evaluate a combination of their experimental ...

Trade negotiations between the United States and Canada are accelerating, with White House economic adviser Kevin Hassett suggesting the two countries are approaching an agreement that could ease ...

Musk subsequently cited Ukrainian President Volodymyr Zelenskyy's acknowledgment that Starlink supports strikes against Russian military targets in occupied Ukrainian territory. Crenshaw countered ...

Netflix remains a strong buy, with fundamentals overshadowed by negative sentiment and a 40% share price decline over the ...

Stock market recap: bank earnings, hotter CPI, tech weakness, and key movers like Meta, Netflix, Tesla, and IBM.

Wall Street investors expecting a rally after the November midterm elections may be disappointed, according to BTIG ...

Analysts see investors rotating out of AI and tech into defensive sectors such as consumer staples and healthcare amid capex ...

The Fed is expected to hold rates steady Wednesday. Microsoft, Alphabet and Amazon earnings put AI spending under scrutiny.

Eaton Vance Limited Duration Income Fund now trades at a deep discount, making it a much more enticing income play. EVV’s ...

AstraZeneca said its experimental stomach cancer treatment doubled survival time in a late-stage clinical trial, ...